These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 2477851)

  • 1. Cerebral vasospasm: resolution by iloprost, nocloprost and UK 38 485.
    Türker RK; Egemen N; Deda H
    Prog Clin Biol Res; 1989; 301():205-9. PubMed ID: 2477851
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental cerebral vasospasm: resolution by iloprost.
    Egemen N; Birler K; Avman N; Türker RK
    Acta Neurochir (Wien); 1988; 95(3-4):131-5. PubMed ID: 2465677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of prostacyclin on cerebral vasospasm--an experimental study].
    Quintana L; Konda R; Ishibashi Y; Okada H; Suzuki J
    No Shinkei Geka; 1982 Oct; 10(10):1049-52. PubMed ID: 6757779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental cerebral vasospasm in cats: modification by a new synthetic vasodilator YC-93.
    Handa Y; Yoneda S; Koyama T; Matsuda M; Handa H
    Surg Neurol; 1975 Apr; 3(4):195-9. PubMed ID: 1145417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of procainamide and chloramphenicol on acute vasospasm.
    Fox JL
    Surg Neurol; 1977 Dec; 8(6):419-22. PubMed ID: 594880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cerebral vascular effects of a new derivative of 1,4-dihydropyridine (YC-93), with special reference to its effect on the experimental basilar artery spasm in cats (author's transl)].
    Handa J
    Nihon Geka Hokan; 1975 Jul; 44(4):343-51. PubMed ID: 1238067
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of new chemically and metabolically stable prostacyclin analogues (iloprost and ZK 96480) on early consequences of a transient cerebral oligemia, in the rat.
    Borzeix MG; Cahn R; Cahn J
    Prostaglandins; 1988 May; 35(5):653-64. PubMed ID: 2456591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of nimodipine and papaverine on delayed cerebral vasospasm in dogs].
    Liu F; Liu D; Rao M
    Zhonghua Yi Xue Za Zhi; 1996 Feb; 76(2):132-4. PubMed ID: 8758447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cerebral vasospasm: comparison of contractile responses in isolated human and canine basilar arteries].
    Tanishima T
    No To Shinkei; 1983 Apr; 35(4):323-9. PubMed ID: 6575794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of phenoxybenzamine on the experimental cerebral vasospasm in cats (author's transl)].
    Handa J; Koyama T; Yoneda S; Matsuda M; Handa H
    No Shinkei Geka; 1975 Jul; 3(7):577-84. PubMed ID: 1237809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of cerebral vasospasm.
    Peterson EW; Mandy FF; Searle R; Leblanc R
    Lancet; 1973 Jun; 1(7818):1513. PubMed ID: 4123178
    [No Abstract]   [Full Text] [Related]  

  • 12. Ther reversal of experimental vasospasm by dibutyryl-3',5'-adenosine monophosphate.
    Peterson EW; Searle R; Mandy FF; Leblanc R
    J Neurosurg; 1973 Dec; 39(6):730-4. PubMed ID: 4357243
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of prostacyclin on cerebral vasospasm. An experimental study.
    Quintana L; Konda R; Ishibashi Y; Yoshimoto T; Suzuki J
    Acta Neurochir (Wien); 1982; 62(3-4):187-93. PubMed ID: 7048862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification, characterization, and functional role of phosphodiesterase type IV in cerebral vessels: effects of selective phosphodiesterase inhibitors.
    Willette RN; Shiloh AO; Sauermelch CF; Sulpizio A; Michell MP; Cieslinski LB; Torphy TJ; Ohlstein EH
    J Cereb Blood Flow Metab; 1997 Feb; 17(2):210-9. PubMed ID: 9040501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of Iloprost on chronic cerebral vasospasm.
    Egemen N; Türker RK; Sandlidilek U; Zorlutuna A; Başkaya M; Bilgiç S; Cağlar S; Unlü A
    Gen Pharmacol; 1993 Mar; 24(2):403-9. PubMed ID: 7683301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral vessels in spasm show an enhanced response to calmodulin antagonists.
    Doi M; Cook D
    Proc West Pharmacol Soc; 1992; 35():81-5. PubMed ID: 1502245
    [No Abstract]   [Full Text] [Related]  

  • 17. Cerebrovascular selectivity and vasospasmolytic action of the novel calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]oxepin-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate in isolated cerebral arteries of the rabbit and dog.
    Minato H; Hashizume M; Masuda Y; Fujitani B; Hosoki K
    Arzneimittelforschung; 1997 Apr; 47(4):339-46. PubMed ID: 9150852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic administration of phosphodiesterase V inhibitor, sildenafil citrate, for attenuation of cerebral vasospasm after experimental subarachnoid hemorrhage.
    Atalay B; Caner H; Cekinmez M; Ozen O; Celasun B; Altinors N
    Neurosurgery; 2006 Nov; 59(5):1102-7; discussion 1107-8. PubMed ID: 17143244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic determination of the role of autonomic receptor sites in cerebral vasospasm.
    Dawson WN; White RP; Robertson JT
    Surg Forum; 1973; 24():455-6. PubMed ID: 4806060
    [No Abstract]   [Full Text] [Related]  

  • 20. Impairment in biochemical level of arterial dilative capability of a cyclic nucleotides-dependent pathway by induced vasospasm in the canine basilar artery.
    Todo H; Ohta S; Wang J; Ichikawa H; Ohue S; Kumon Y; Sakaki S
    J Cereb Blood Flow Metab; 1998 Jul; 18(7):808-17. PubMed ID: 9663510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.